| HOME >> BIOLOGY >> TECHNOLOGY |
SuperGen, Inc. SuperGen, Inc.
SVP, Corporate Communications Manager, Investor Relations
& Business Development
Tel: (925) 560-0100 Tel: (925) 560-2845
E-mail: tenns@supergen.com E-mail: mary.vegh@supergen.com
Condensed Consolidated Statements of Operations and Balance Sheets
to follow ...
SUPERGEN, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 2008 2007
Revenues:
Net product revenue $- $- $- $621
Royalty revenue 8,133 4,619 16,271 8,413
Total revenues 8,133 4,619 16,271 9,034
Costs and operating expenses:
Cost of product revenue - - - 221
Research and development 7,740 5,953 15,687 11,015
Selling, general,
and administrative 3,273 3,697 6,350 7,273
Acquired in-process
research and
development - 9,967 - 9,967
Gain on sale of
products (560) (25,849) (1,560) (25,849)
Total costs and
operating expenses 10,453 (6,232) 20,477 2,627
Income (loss) from
operations (2,320) 10,851 (4,206) 6,407
'/>"/>
| SOURCE SuperGen, Inc. Copyright©2008 PR Newswire. All rights reserved |